Found: 12
Select item for more details and to access through your institution.
Mutagenesis of GPR139 reveals ways to create gain or loss of function receptors.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 1, p. 1, doi. 10.1002/prp2.466
- By:
- Publication type:
- Article
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans.
- Published in:
- Translational Psychiatry, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41398-020-00937-9
- By:
- Publication type:
- Article
Probing the Functional Domains of Relaxin-3 and the Creation of a Selective Antagonist for RXFP3/GPCR135 over Relaxin Receptor RXFP1/LGR7.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1160, p. 31, doi. 10.1111/j.1749-6632.2008.03790.x
- By:
- Publication type:
- Article
In Vitro Pharmacological Characterization of RXFP3 Allosterism: An Example of Probe Dependency.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0030792
- By:
- Publication type:
- Article
Recent Progress in Relaxin-3--Related Research.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1041, n. 1, p. 47, doi. 10.1196/annals.1282.009
- By:
- Publication type:
- Article
In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-B.
- Published in:
- Cellular & Molecular Life Sciences, 2024, v. 81, n. 1, p. 1, doi. 10.1007/s00018-024-05308-x
- By:
- Publication type:
- Article
In vitro and in vivo characterization of JNJ-31020028 ( N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y<sub>2</sub> receptor
- Published in:
- Psychopharmacology, 2010, v. 208, n. 2, p. 265, doi. 10.1007/s00213-009-1726-x
- By:
- Publication type:
- Article
Identification and characterization of select oxysterols as ligands for GPR17.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 4, p. 401, doi. 10.1111/bph.15969
- By:
- Publication type:
- Article
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00357
- By:
- Publication type:
- Article
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
- Published in:
- British Journal of Pharmacology, 2013, v. 170, n. 3, p. 624, doi. 10.1111/bph.12314
- By:
- Publication type:
- Article
G-Protein-Coupled Receptor (GPCR)-142 Does Not Contribute to Relaxin-3 Binding in the Mouse Brain: Further Support that Relaxin-3 Is the Physiological Ligand for GPCR135.
- Published in:
- Neuroendocrinology, 2005, v. 82, n. 3/4, p. 139, doi. 10.1159/000091267
- By:
- Publication type:
- Article
Distribution of G-Protein-Coupled Receptor (GPCR)135 Binding Sites and Receptor mRNA in the Rat Brain Suggests a Role for Relaxin-3 in Neuroendocrine and Sensory Processing.
- Published in:
- Neuroendocrinology, 2004, v. 80, n. 5, p. 298, doi. 10.1159/000083656
- By:
- Publication type:
- Article